SHS Newsletter

The European Medical Device Regulation (MDR), whose goals were initially supported by the European medtech industry, has been in force since May 2022. After half a year, the situation for the medium-sized medtech industry is devastating.

Blazejewski MEDI-TECH GmbH is one of the technology leaders in the field of complex 2D and 3D endoscopy and has been able to grow very strongly in recent years Reinhold Blazejewski, Founder and Managing Director of Blazejewski MEDI-TECH, also sells part of his shares to the Erbe Group, but remains with the company as a […]

At the beginning of the Corona pandemic, many market participants were looking for investment opportunities in the health market. Companies like BioNTech, which had previously remained niche, became stock market stars. Can investors also profit from the transition to endemicity?

Medium-sized medical technology companies are facing many challenges in these geopolitically turbulent times: Supply chain problems, the MDR medical device regulation, digitalisation, energy shortages and rising refinancing costs due to the jump in interest rates. It’s good to have a solid capital base.

The most important goals in the invasive treatment of myocardial infarction are to reduce infarct size, improve cardiac function and minimise the likelihood of permanent heart failure. To achieve these goals, Belgium-based Miracor Medical has developed the PiCSO® (Pressore Controlled Intermittent Coronary Sinus Occlusion) system. With the start of the new PICSO-AMI-V study at the […]

Tübingen, 3 November 1906: Alzheimer’s disease described for the first time 3 November 1906 is an important date in the history of Alzheimer’s disease. For on this Saturday, the physician Dr. Alois Alzheimer (14.6.1864 – 19.12.1915) described a type of dementia disease for the first time at a specialist conference at the Tübingen Nervenklinik. Alzheimer, […]

In our series “SHS portfolio companies”, today we talk to Reinhold Blazejewski, founder and managing partner of Blazejewski MEDI-TECH GmbH, which produces high-tech endoscopes as an OEM manufacturer for the global market in Sexau, Baden. SHS has held a stake in the MedTech SME since January 2020. Reinhold Blazejewski is what is called a tinkerer […]

With the CARLO® surgical robot for high-precision laser cutting of bones, the Swiss medical robotics company AOT has already made technological history in the operating theatre. More than 80 procedures have already been successfully performed on patients with CARLO®. The system is CE-certified for all of Europe. Now the medical robotics experts at AOT have […]

SHS enjoys a very good reputation as a specialised healthcare investor among companies and institutional investors because it draws on a strong network of experts. The medical-technical healthcare experts who support SHS and the portfolio companies play a special role here. Professor Dr Arnulf Stenzl has been Medical Director of the Department of Urology at […]

The medical technology industry has not exactly had it easy in the last two years. In addition to the pandemic, which has shaken the industry, the MDR (Medical Device Regulation) of the EU and digitalisation in particular present companies with major challenges that tie up manpower and capital. In addition, there are now pandemic-related supply […]

Here we introduce you to the SHS senior advisors. The experience of these experts plays an important role for us in the investment process and benefits not least our portfolio companies. Professor Dr. rer. nat. Armin Bolz was Professor of Biomedical Engineering at KIT from 1999 to 2013. At the same time, he founded and […]

Founded in 2013, our portfolio company Lowenco is already one of the leading providers of ultra-low temperature solutions for the global biopharma industry after just a few years. A success that is also reflected in the company’s books. As of 31.12.2021, Lowenco reports an increase in operating profit of around 32 percent to now 80 […]